2020 WSES guidelines for the detection and management of bile duct injury during cholecystectomy

 

Executive Summary

Bile duct injury (BDI) represents a severe complication of cholecystectomy, characterized by significant morbidity, mortality (up to 3.5%), and a long-term detrimental impact on patient quality of life. While the incidence is relatively low (0.4–1.5% in laparoscopic cholecystectomy), the global volume of these procedures makes BDI a persistent surgical challenge.

The 2020 World Society of Emergency Surgery (WSES) guidelines emphasize a multidisciplinary approach involving surgeons, radiologists, and gastroenterologists. Critical takeaways include:

  • Prevention: The "Critical View of Safety" (CVS) is the gold standard for minimizing risk.

  • Reporting: Standardized documentation using the ATOM or Strasberg classifications is essential for subsequent management.

  • Management: Successful outcomes are heavily dependent on the timing of repair and the involvement of hepato-pancreato-biliary (HPB) specialists.

  • Strategy: For major injuries, an "on-table" repair (within 72 hours) or a delayed repair (after 3 weeks) is recommended to avoid the peak inflammatory phase.

Epidemiology and Clinical Impact

Biliary injuries have become more frequent—and often more severe—since the widespread adoption of laparoscopy.

Procedure Type

Major BDI Rate

Overall BDI Rate

Elective Laparoscopic

0.1%

0.4%

Emergency Laparoscopic

0.3%

0.8%

Open Cholecystectomy

N/A

0.2–0.3%

Key Prognostic Factors:

  • Delayed Detection: Associated with nearly double the 1-year mortality risk compared to non-injured patients (Hazard Ratio: 1.95).

  • Vascular Involvement: Concomitant injuries to the right hepatic artery or portal vein significantly increase the risk of liver ischemia, necrosis, and repair failure.

  • Litigation: Between 19% and 32% of BDI cases in Europe result in medicolegal claims.

Strategies for Risk Minimization

To minimize iatrogenic injury, surgeons should adhere to technical and procedural safeguards:

  • Critical View of Safety (CVS): Mandatory routine use is recommended. It requires identifying three components before ligating the cystic duct/artery:

    • Clearance of the hepatocystic triangle (fat and fibrous tissue removed).

    • Clearance of the lower third of the gallbladder from the liver bed.

    • Visualization of only two structures entering the gallbladder.

  • Bailout Procedures: If CVS cannot be achieved due to inflammation or fibrosis, surgeons should transition to subtotal cholecystectomy (STC) or cholecystostomy rather than persisting with difficult dissection.

  • Timing in Acute Cholecystitis (AC): Optimal surgery should occur within 48 hours and no later than 10 days from symptom onset to avoid advanced inflammatory progression.

  • Intraoperative Imaging:

    • IOC (Cholangiography): Recommended selectively for suspected injury or anatomical ambiguity.

    • ICG-C (Fluorescence): A promising, non-invasive tool for real-time biliary tree visualization.

Classification and Standardized Reporting

Accurate classification facilitates the decision-making process for reconstructive strategies.

Comparison of Primary Classification Systems

System

Focus

Strength

Strasberg

Anatomical location and type of leak/obstruction.

Most commonly used in clinical practice.

ATOM

Anatomic level, Time of detection, and Mechanism.

Most comprehensive; includes vascular involvement.

Bismuth

Level of injury relative to the biliary confluence.

Useful for planning reconstructive surgery.

Minimum Required Information for Operative Reports

The guidelines advocate for "synoptic surgery reporting" to include:

  1. Clinical context and indication for surgery.

  2. Clear description of anatomical landmarks and CVS components.

  3. Details of anatomical variations (e.g., aberrant ducts, short cystic duct).

  4. Operative data: energy devices used, blood loss, and conversion to open surgery.

  5. Visual aids: Drawings of the injury and/or videotape of the procedure.

Management of Intraoperatively Detected BDI

If an injury is identified during surgery, the immediate priority is assessment by an experienced surgeon.

  • Minor Injuries (Strasberg A–D): May be managed via direct repair (with or without a T-tube) or abdominal drainage.

  • Major Injuries (Strasberg E): Require Roux-en-Y hepaticojejunostomy.

  • The Expertise Factor: Repairs attempted by non-HPB specialists are independent risk factors for biliary strictures and recurrent cholangitis. If local HPB expertise is unavailable, the surgeon should "drain now and fix later," referring the patient to a tertiary center.

  • Vascular Injuries: Immediate repair of isolated right hepatic artery injuries is not routinely recommended due to high technical complexity and limited clinical impact on the liver (provided the portal vein is intact).

Postoperative Diagnosis and Investigation

Patients who fail to recover rapidly after cholecystectomy must be screened for alarm symptoms: fever, abdominal pain, jaundice, nausea, and vomiting.

Diagnostic Hierarchy

  1. Biochemical Tests: Assessment of LFTs (bilirubin, ALP, GGT) and inflammatory markers (CRP, PCT, lactate).

  2. Ultrasonography (US): First-line tool for detecting collections and ductal dilation.

  3. Triphasic CT: Superior for identifying fluid collection morphology, site, and vascular complications.

  4. MRCP/CE-MRCP: The gold standard for morphological evaluation. Contrast-enhanced MRCP (using hepatocyte-specific agents) has nearly 100% accuracy in localizing bile leaks.

Management of Postoperatively Detected BDI

Management depends on the type of injury and the time elapsed since the index surgery.

  • Minor BDI Step-up Approach:

    • Observation and drainage.

    • Endoscopic management (ERCP with sphincterotomy and/or stenting) if symptoms worsen. ERCP has a success rate of 87–100% for minor leaks.

  • Major BDI Timing:

    • < 72 Hours: Immediate referral and urgent surgical repair if HPB expertise is available.

    • 72 Hours to 3 Weeks: High inflammatory phase; management should focus on percutaneous drainage, antibiotics, and nutritional support.

    • > 3 Weeks: Reconstructive surgery (Roux-en-Y hepaticojejunostomy) once the acute inflammatory situation has resolved.

  • Biliary Peritonitis: Requires urgent abdominal cavity lavage and drainage as a primary step for infection source control.

Antibiotic Protocols

Antibiotics serve as a complement to source control (drainage).

Scenario

Recommended Antibiotic

Suspected BDI (Elective)

Broad-spectrum prophylaxis.

Previous Biliary Infection

4th-generation cephalosporins (e.g., Cefepime).

Biliary Fistula / Peritonitis

Piperacillin/tazobactam or Carbapenems (Meropenem/Imipenem).

Sepsis/Shock

Add Amikacin; Fluconazole for fragile patients.


Long-Term Outcomes

Success rates for BDI treatment are generally high, but late complications are frequent:

  • Anastomotic Strictures: Incidence of 10–20%, typically forming 11–30 months post-repair.

  • Biliary Cirrhosis: Occurs in 2.4–10.9% of cases.

  • Mortality: BDI-related mortality ranges from 1.8% to 4.6%.

  • Quality of Life: Many patients suffer permanent work-related limitations and loss of productivity even years after a successful repair.